November 18, 2025

Plozasiran Wins FDA Nod for FCS

Arrowhead’s small interfering RNA therapy reduced triglycerides and lowered pancreatitis risk in the phase 3 PALISADE trial, providing a quarterly self-administered option for patients with familial chylomicronemia syndrome.

Conexiant

November 15, 2025

Artificial Intelligence in Health Care: The Ethical Frontier

At AMP 2025, Takunda Matose, PhD, urged pathologists to consider the limitations of big data and probabilistic reasoning to maximize AI’s benefits for clinical outcomes.

Conexiant

November 14, 2025

Michael Laposata Receives Champion for Innovation Award

At AMP’s annual meeting, the organization also honored Alexis Carter, Dara Aisner, and Lawrence Jennings for their contributions to laboratory medicine and molecular pathology.

Conexiant

November 05, 2025

Shame in Medicine—A Quiet Epidemic

A new movement in medicine aims to teach “shame competence,” helping physicians recognize and manage one of the field’s most corrosive yet overlooked emotions.

KFF Health News

October 29, 2025

H-1B Visa Changes: Who Pays the Price?

New fee structure could hit hardest where physicians are needed most.

Conexiant

September 03, 2025

Policy Shift Adjusts NIH Peer Review Role

New NIH funding rules shift decision-making power from peer review panels to political appointees in determining future scientific grants.

KFF Health News

September 16, 2025

State’s Largest HIV Outbreak Raises Alarms

Public health experts cite syringe shortages and encampment clearings as drivers of Penobscot County’s historic HIV outbreak.

KFF Health News

September 17, 2025

‘Death by a Thousand Cuts’

Rural South Texas hospitals and physicians face mounting strain as rising uninsured rates and federal funding cuts threaten access to essential health care.

KFF Health News

September 24, 2025

Who Holds the Power on Vaccines Now?

Vaccine recommendations face increasing state-level variation following ACIP and CDC changes.

KFF Health News